Aberdeen Group’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$490K Sell
6,357
-11,917
-65% -$869K ﹤0.01% 887
2026
Q1
$1.19M Sell
18,274
-829
-4% -$61.6K ﹤0.01% 807
2025
Q4
$1.51M Buy
19,103
+224
+1% +$17.2K ﹤0.01% 802
2025
Q3
$1.36M Sell
18,879
-4,341
-19% -$318K ﹤0.01% 814
2025
Q2
$1.76M Buy
23,220
+1,804
+8% +$128K ﹤0.01% 788
2025
Q1
$1.6M Sell
21,416
-162,114
-88% -$12.1M ﹤0.01% 781
2024
Q4
$12.1M Buy
183,530
+834
+0.5% +$58.4K 0.02% 473
2024
Q3
$12.3M Sell
182,696
-55,625
-23% -$3.35M 0.02% 477
2024
Q2
$12.6M Buy
+238,321
New +$14.5M 0.02% 470

Other funds holding SOLV

Aberdeen Group's SOLV Position: Q2 2026 in Review

Aberdeen Group reduced its Solventum (SOLV) stake by 65% in Q2 2026, selling an estimated $869K and leaving 6,357 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #887.

Aberdeen Group first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.6M in Q2 2024. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Aberdeen Group held 6,357 shares of Solventum worth $490K as of Q2 2026.
  • Aberdeen Group sold 11,917 Solventum shares in Q2 2026, an estimated $869K.
  • Solventum made up ﹤0.01% of Aberdeen Group's portfolio in Q2 2026, its #887 holding.
  • Aberdeen Group first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Aberdeen Group's Solventum position peaked at $12.6M in Q2 2024.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.